Clinical trial
Artificial Intelligence-Based Disease Management in the Vulnerable Period of Heart Failure
NCT05544006
Drugs and interventions used in this trial
0 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No interventions are currently published for this study in CureCurrent. View the original registry record below.
Study at a glance
Registry-backedArtificial Intelligence-Based Disease Management in the Vulnerable Period of Heart Failure
Design: OBSERVATIONAL · Status: UNKNOWN · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Heart Failureverified · MONDO: heart failure
Interventions
Sponsors & collaborators
Albert Saglik Hizmetleri ve Ticaret A.S.lead sponsor
Dokuz Eylul Universitycollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05544006 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.